She paused for a moment, as if choosing her words carefully: "However, the difficulty of its engineering realization increases exponentially. The design, expression, purification, and antigen connection efficiency of each enhancer module, the stability of the composite after connection, immunogenicity, safety... Each step is filled with unknowns and risks of failure. My personal assessment is that the likelihood of its successful application is infinitesimally close to zero."
An elderly but still sharp-eyed technical vice president, Charles White, spoke slowly, his voice low and clear: "Sounds like another project trying to impress investors with pretty theories. Do they have any actual progress? For instance, are there any design ideas for these so-called enhancers?"
"According to our very limited intelligence sources," the female scientist replied, "their work has just begun, with no substantial progress."
